Iron addiction: a novel therapeutic target in ovarian cancer
about
Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice.Serum ferritin and primary lung cancer.Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth.Necroptotic cell death in anti-cancer therapy.Expression and function of nuclear receptor coactivator 4 isoforms in transformed endometriotic and malignant ovarian cells.Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer.
P2860
Q38637192-10CBD88F-E40D-4801-B85A-90367DC62BC8Q44893565-1CA6DEC0-F1B4-4217-A0D4-D362CE8C3BA0Q47094158-363ACB62-A511-4BA3-8030-16C53B42912CQ47164877-354F5DA8-9BE1-4578-BD37-F28D768ABF35Q47659073-89F20C71-73F4-459C-802E-33E86B3DA4EBQ50052852-190B5F28-B3AF-4B26-BD96-B038D6338117Q55497286-8274C2D6-59E4-4A1A-B320-75DC52BF2707
P2860
Iron addiction: a novel therapeutic target in ovarian cancer
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Iron addiction: a novel therapeutic target in ovarian cancer
@en
type
label
Iron addiction: a novel therapeutic target in ovarian cancer
@en
prefLabel
Iron addiction: a novel therapeutic target in ovarian cancer
@en
P2093
P2860
P356
P1433
P1476
Iron addiction: a novel therapeutic target in ovarian cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2017.11
P407
P50
P577
2017-03-20T00:00:00Z
P6179
1084129908